Full-text search

Results for “CarMax, Inc”

Search across the indexed text of every released document.

Names that match “CarMax, Inc”

HBRK Associates Inc · 73 ROYAL SAXON INC CO-OP · 59 REGENCY OF PALM BEACH INC · 52 PARK PLACE INC CO-OP · 27 New York Post Publishing INC · 18 USA Inc · 15

1,408 documents found

USA Inc.’s financial liabilities -- whether they are actual

document e Unless they are reduced House Oversight Committee — Epstein Estate Records (Nov 2025)

USA Inc.’s financial liabilities -- whether they are actual

and/or was involved in Novamente LLC and Webmind Inc

document involved with the OpenCog project House Oversight Committee — Epstein Estate Records (Nov 2025)

and/or was involved in Novamente LLC and Webmind Inc.

Inc. Therapeutics 7.7 19.4 - 19.4 2.51 2.51 581.9%

document Acadia Phamaceuticals House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Therapeutics 7.7 19.4 - 19.4 2.51 2.51 581.9%

Inc. Therapeutics 2013 10.4 11.1 - 11.1 1.06 1.06 13.1%

document Ambit Biosciences House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Therapeutics 2013 10.4 11.1 - 11.1 1.06 1.06 13.1%

Inc. Convergence 2011 88: 125 1.6 14.1 - 3.68 105.6%

document Audax Health Solutions House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Convergence 2011 88: 125 1.6 14.1 - 3.68 105.6%

Inc. Therapeutics 2011 20.6 27.0 44.9 71.9 3.07 3.50 57.7%

document Chimerix House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Therapeutics 2011 20.6 27.0 44.9 71.9 3.07 3.50 57.7%

Inc. Therapeutics 2013 3.4 6.8 - 6.8 2.03 2.03 1583.0%

document Epizyme House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Therapeutics 2013 3.4 6.8 - 6.8 2.03 2.03 1583.0%

Inc. Diagnostics & Infrastructure 2008 10.7 - - - - - NM

document Glumetrics House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Diagnostics & Infrastructure 2008 10.7 - - - - - NM

Inc. Therapeutics 2012 10.5 34.1 - 34.1 3.24 3.24 323.6%

document Intercept Pharmaceuticals House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Therapeutics 2012 10.5 34.1 - 34.1 3.24 3.24 323.6%

Inc. Therapeutics 2011 2.4 02 - 0.2 0.07 0.07 -91.6%

document Kalidex Pharmaceuticals House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Therapeutics 2011 2.4 02 - 0.2 0.07 0.07 -91.6%

Inc. Therapeutics 2012 9.0 10.2 35.8 46.0 2.94 5.12 423.2%

document MEI Pharma House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Therapeutics 2012 9.0 10.2 35.8 46.0 2.94 5.12 423.2%

Inc. Therapeutics 2009 11.0 - - - - - NM

document Presidio Pharmaceuticals House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Therapeutics 2009 11.0 - - - - - NM

Inc. Healthcare Devices 2008 17.0 1.8 - 1.8 0.11 0.11 NM

document Worldheart House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Healthcare Devices 2008 17.0 1.8 - 1.8 0.11 0.11 NM

Inc. Diagnostics & Infrastructure 2012 9.0 - 9.0 9.0 - 1.00 -0.4%

document Advanced Cell Diagnostics House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Diagnostics & Infrastructure 2012 9.0 - 9.0 9.0 - 1.00 -0.4%

Inc. Therapeutics 2009 11.2 - 11.2 11.2 - 1.00 0.0%

document Afferent Pharmaceuticals House Oversight Committee — Epstein Estate Records (Nov 2025)

Inc. Therapeutics 2009 11.2 - 11.2 11.2 - 1.00 0.0%